| From | Immunization Action Coalition <[email protected]> |
| Subject | IAC Express #1469 |
| Date | December 18, 2019 1:11 PM |
Links have been removed from this email. Learn more in the FAQ.
Links have been removed from this email. Learn more in the FAQ.
Email not displaying correctly? View it in your browser. ([link removed])
[link removed]
Issue 1469: December 18, 2019
-TOP STORIES-
* Happy holidays from all of us at IAC! We'll be back on January 8. )
* WHO and CDC issue joint press release reporting more than 140,000 died from measles worldwide in 2018 and urging increased global investment in immunization and response
* CDC updates ACIP recommendations on use of anthrax vaccine in the U.S.
* Reminder: National Adult and Influenza Immunization Summit soliciting nominations for its 2020 Immunization Excellence Awards
* IAC's elegantly designed "Vaccines Save Lives" black enamel pins make great gifts for the holidays!
* Flu season is here, so make sure you have IAC's new "FLU VACCINE" buttons for staff and patient stickers on hand!
-VACCINE INFORMATION STATEMENTS-
* Updated translations of the PPSV23 VIS are now available in Arabic, Burmese, Chinese, French, Russian, Somali, Spanish, and Vietnamese
* IAC posts updated translations of both zoster recombinant and zoster live VISs in Arabic, Burmese, Chinese, French, Korean, Russian, Somali, Spanish, and Vietnamese; Spanish-language RTF files also available
* Updated Turkish translations of the PPSV23, typhoid, zoster recombinant, and zoster live VISs now available
* IAC posts new and updated Karen translations of the PPSV23, zoster recombinant, and zoster live VISs
* New Hindi-language version of the Japanese encephalitis VIS now available
WORLD NEWS
* Democratic Republic of the Congo, experiencing world’s largest measles epidemic, launches phase 2 of campaign to vaccinate 18.9 million children by end of 2019
* Pakistan, first country worldwide to introduce typhoid conjugate vaccine into its routine immunization program, vaccinates 9.4 million children against typhoid fever in Sindh province
-FEATURED RESOURCES-
* Seasonal influenza activity in the U.S. elevated for five weeks and continues to increase. Make sure all your patients are getting vaccinated!
* New 16-minute personal background film about Dr. Maurice Hilleman released by the Vaccine Makers Project at VEC
* NFID’s redesigned website brings together the organization’s valuable information and resources for the public and healthcare professionals
* IAC's comprehensive Vaccinating Adults: A Step-by-Step Guide is available for free download either by chapter or in its entirety (142 pages) )
-JOURNAL ARTICLES AND NEWSLETTERS-
* JAMA Pediatrics study finds need for strategies to increase MMR vaccination rates among pediatric travelers to reduce measles outbreaks in the U.S.
------------------------------------------------------------
-TOP STORIES-
------------------------------------------------------------
HAPPY HOLIDAYS FROM ALL OF US AT IAC! WE'LL BE BACK ON JANUARY 8.
All of us at the Immunization Action Coalition (IAC) wish you, our readers, a safe, happy, and relaxing holiday season. Because of the holiday schedule, we will not publish another issue of IAC Express until January 8. The IAC office will be closed on December 24 and 25, as well as January 1.
Happy holidays!
------------------------------------------------------------
WHO AND CDC ISSUE JOINT PRESS RELEASE REPORTING MORE THAN 140,000 DIED FROM MEASLES WORLDWIDE IN 2018 AND URGING INCREASED GLOBAL INVESTMENT IN IMMUNIZATION AND RESPONSE
On December 5, the World Health Organization (WHO) and CDC issued a joint press release ([link removed]) highlighting the surge in worldwide measles cases in 2018. The press release stresses the risk for complications among infants and young children, with most deaths from complications occurring in children under 5 years of age. Populations that are hardest hit by measles outbreaks are those in the poorest countries, especially in sub-Saharan Africa. The joint statement calls for ongoing investment in high-quality national immunization programs and disease surveillance in addition to improved outbreak response.
Access the complete press release: More than 140,000 Die from Measles as Cases Surge Worldwide ([link removed]) (12/5/19)
Related Links
* MMWR: Progress toward Regional Measles Elimination—Worldwide, 2000–2017 ([link removed]) (11/30/18)
* WHO news release: Measles Cases Spike Globally Due to Gaps in Vaccination Coverage ([link removed]) (11/29/18)
------------------------------------------------------------
CDC UPDATES ACIP RECOMMENDATIONS ON USE OF ANTHRAX VACCINE IN THE U.S.
CDC published Use of Anthrax Vaccine in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2019 ([link removed]) in the December 13 issue of MMWR Recommendations and Reports. The first paragraph of the summary for the press is reprinted below.
This report updates the 2009 recommendations from the CDC Advisory Committee on Immunization Practices (ACIP) regarding use of anthrax vaccine in the United States (Wright JG, Quinn CP, Shadomy S, Messonnier N. Use of anthrax vaccine in the United States: recommendations of the Advisory Committee on Immunization Practices [ACIP)], 2009. MMWR Recomm Rep 2010;59[No. RR-6]). The report 1) summarizes data on estimated efficacy in humans using a correlates of protection model and safety data published since the last ACIP review, 2) provides updated guidance for use of anthrax vaccine adsorbed (AVA) for preexposure prophylaxis (PrEP) and in conjunction with antimicrobials for postexposure prophylaxis (PEP), 3) provides updated guidance regarding PrEP vaccination of emergency and other responders, 4) summarizes the available data on an investigational anthrax vaccine (AV7909), and 5) discusses the use of anthrax antitoxins for PEP.
Access the complete MMWR article:
* In PDF format ([link removed])
* In HTML format ([link removed])
Related Link
* MMWR main page ([link removed]) provides access to MMWR Weekly, MMWR Recommendations and Reports, MMWR Surveillance Summaries, and MMWR Supplements
------------------------------------------------------------
REMINDER: NATIONAL ADULT AND INFLUENZA IMMUNIZATION SUMMIT SOLICITING NOMINATIONS FOR ITS 2020 IMMUNIZATION EXCELLENCE AWARDS
The National Adult and Influenza Immunization Summit (NAIIS) is soliciting nominations for the 2020 NAIIS Immunization Excellence Awards ([link removed]) . The 2020 awards recognize individuals and organizations that have made extraordinary contributions towards improving vaccination rates within their communities during 2019. Awardees exemplify the meaning of the "immunization neighborhood" (collaboration, coordination, and communication among immunization stakeholders dedicated to meeting the immunization needs of the patient and protecting the community from vaccine-preventable diseases).
A National Winner will be selected for each award category, and where appropriate, an Honorable Mention recipient. The winners will be presented with their awards at the NAIIS meeting to be held on May 18 in Atlanta, GA, in conjunction with CDC’s National Immunization Conference. The National Winners in each category will be invited to present their programs at the NAIIS meeting.
Nominations deadline is February 1, 2020.
Access information on the award categories and the nomination form ([link removed]) .
Related Links
* NAIIS ([link removed]) website
* NAIIS newsletter: The Summit Buzz ([link removed])
------------------------------------------------------------
IAC'S ELEGANTLY DESIGNED "VACCINES SAVE LIVES" BLACK ENAMEL PINS MAKE GREAT GIFTS FOR THE HOLIDAYS!
IAC’s new elegantly designed “Vaccines Save Lives” pin ([link removed]) on hard black enamel with gold lettering and edges makes a meaningful gift for people who care about immunization.
[link removed]
The pin is a stick-through-post variety with the back end covered by a round rubber cap that holds the pin securely. A gold metal spring-lock clasp is also provided. The pin makes a refined statement, measuring 1.125" x 0.75".
Wear these pins on clothing, ([link removed]) uniforms, lab coats, tote bags, and backpacks to show that you value vaccines!
[link removed]
Click here for "Vaccines Save Lives" pins pricing and ordering information. ([link removed])
Visit Shop IAC for additional items ([link removed]) , including "FLU VACCINE" buttons and stickers, patient record cards, and a vaccine administration training video.
------------------------------------------------------------
FLU SEASON IS HERE, SO MAKE SURE YOU HAVE IAC'S NEW "FLU VACCINE" BUTTONS FOR STAFF AND PATIENT STICKERS ON HAND!
IAC's “FLU VACCINE” buttons and stickers ([link removed]) are ready to ship! Their bright red color helps broadcast your important message about the need for flu vaccination. And the cost is nominal.
[link removed]
“FLU VACCINE” BUTTONS
The button measures 1.25" across and carries a bold message! Pin on lab coats, uniforms, other clothing, tote bags, or backpacks to show support for flu vaccine.
Buttons are delivered in bags of 10 buttons per bag.
Click here for pricing and ordering information for "FLU VACCINE" buttons ([link removed]) .
“FLU VACCINE” STICKERS
Measuring 1.5" across and printed on Avery labels, theses stickers adhere well to clothing and have an easy-peel-off back.
Stickers are delivered to you cut individually (not on rolls)—available in bundles of 100.
Click here for pricing and ordering information for “FLU VACCINE” stickers. ([link removed])
Visit Shop IAC for additional items ([link removed]) , including "Vaccines Save Lives" enamel pins, patient record cards, and a vaccine administration training video.
------------------------------------------------------------
-VACCINE INFORMATION STATEMENTS-
------------------------------------------------------------
UPDATED TRANSLATIONS OF THE PPSV23 VIS ARE NOW AVAILABLE IN ARABIC, BURMESE, CHINESE, FRENCH, RUSSIAN, SOMALI, SPANISH, AND VIETNAMESE
IAC recently posted updated Arabic, Burmese, Chinese, French, Russian, Somali, Spanish, and Vietnamese translations of the PPSV23 VIS ([link removed]) . Access these updated translated versions below.
* Arabic-language version ([link removed])
* Burmese-language version ([link removed])
* Chinese-Simplified version ([link removed])
* Chinese-Traditional version ([link removed])
* French-language version ([link removed])
* Russian-language version ([link removed])
* Somali-language version ([link removed])
* Spanish-language version ([link removed])
* Spanish-language RTF version ([link removed])
* Vietnamese-language version ([link removed])
Related Links
* Access all PPSV23 VIS translations ([link removed]) , as well as the English-language version ([link removed])
* Access allhttp://www.immunize.org/vis/vis_amharic.aspArabic-language versions of VISs ([link removed])
* Access allBurmese-language versions of VISs ([link removed])
* Access allhttp://www.immunize.org/vis/vis_amharic.aspChinese-language versions of VISs ([link removed])
* Access allhttp://www.immunize.org/vis/vis_amharic.aspFrench-language versions of VISs ([link removed])
* Access allRussian-language versions of VISs ([link removed])
* Access allhttp://www.immunize.org/vis/vis_amharic.aspSomali-language versions of VISs ([link removed])
* Access allhttp://www.immunize.org/vis/vis_amharic.aspSpanish-language versions of VISs ([link removed])
* Access all ([link removed]) Vietnamese-language versions of VISs ([link removed])
* Access allVIS translations categorized by language ([link removed])
* IAC's VIS web section ([link removed]) for VISs in up to 50 languages ([link removed])
* CDC's What's New with VISs ([link removed]) web section
* CDC's VIS ([link removed]) web section
* View more than 300 CDC-reviewed, ready-to-print IACEducational Materials for Patients and Staff ([link removed])
------------------------------------------------------------
IAC POSTS UPDATED TRANSLATIONS OF BOTH ZOSTER RECOMBINANT AND ZOSTER LIVE VISS IN ARABIC, BURMESE, CHINESE, FRENCH, KOREAN, RUSSIAN, SOMALI, SPANISH, AND VIETNAMESE; SPANISH-LANGUAGE RTF FILES ALSO AVAILABLE
IAC recently posted updated Arabic, Burmese, Chinese, French, Korean, Russian, Somali, Spanish, and Vietnamese translations of the VISs for both the zoster recombinant (Shingrix, GlaxoSmithKline) ([link removed]) and the zoster live vaccine (Zostavax, Merck) ([link removed]) . Access the updated translated versions below.
Zoster recombinant VIS
* Arabic-language version ([link removed])
* Burmese-language version ([link removed])
* Chinese-Simplified version ([link removed])
* Chinese-Traditional version ([link removed])
* French-language version ([link removed])
* Korean-language version ([link removed])
* Russian-language version ([link removed])
* Somali-language version ([link removed])
* Spanish-language version ([link removed]) (PDF)
* Spanish-language version ([link removed]) (RTF)
* Vietnamese-language version ([link removed])
Zoster live VIS
* Arabic-language version ([link removed])
* Burmese-language version ([link removed])
* Chinese-Simplified version ([link removed])
* Chinese-Traditional version ([link removed])
* French-language version ([link removed])
* Korean-language version ([link removed])
* Russian-language version ([link removed])
* Somali-language version ([link removed])
* Spanish-language version ([link removed]) (PDF)
* Spanish-language version ([link removed]) (RTF)
* Vietnamese-language version ([link removed])
RTF files are intended for use in electronic systems, such as electronic medical records, immunization information systems, or other electronic databases. CDC supplies RTF files of the English-language VISs, and IAC provides Spanish RTF files of VISs for each routinely recommended vaccine.
Related Links
* Access all zoster recombinant VIS translations ([link removed]) , as well as the English-language version ([link removed])
* Access all zoster live VIS translations ([link removed]) , as well as the English-language version ([link removed])
* Access allhttp://www.immunize.org/vis/vis_amharic.aspArabic-language versions of VISs ([link removed])
* Access allhttp://www.immunize.org/vis/vis_amharic.aspBurmese-language versions of VISs ([link removed])
* Access all Chinese-language versions of VISs ([link removed])
* Access allhttp://www.immunize.org/vis/vis_amharic.aspFrench-language versions of VISs ([link removed])
* Access allhttp://www.immunize.org/vis/vis_amharic.aspKorean-language versions of VISs ([link removed])
* Access allhttp://www.immunize.org/vis/vis_amharic.aspRussian-language versions of VISs ([link removed])
* Access allhttp://www.immunize.org/vis/vis_amharic.aspSomali-language versions of VISs ([link removed])
* Access allhttp://www.immunize.org/vis/vis_amharic.aspSpanish-language versions of VIS ([link removed]) s ([link removed])
* Access allhttp://www.immunize.org/vis/vis_amharic.aspVietnamese-language versions of VISs ([link removed])
* Access allVIS translations categorized by language ([link removed])
* IAC's VIS web section ([link removed]) for VISs in up to 50 languages ([link removed])
* CDC's What's New with VISs ([link removed]) web section
* CDC's VIS ([link removed]) web section
* View more than 300 CDC-reviewed, ready-to-print IACEducational Materials for Patients and Staff ([link removed])
------------------------------------------------------------
UPDATED TURKISH TRANSLATIONS OF THE PPSV23, TYPHOID, ZOSTER RECOMBINANT, AND ZOSTER LIVE VISS NOW AVAILABLE
IAC has posted updated Turkish-language versions of the PPSV23, typhoid, zoster recombinant, and zoster live VISs. IAC thanks Betül Polatdemir, MD, and Sibel Bostancıoğlu, MD, Occupational and Environmental Diseases Hospital, Ankara, Turkey, for their donation of the Turkish translations. Access these Turkish-language versions below.
* PPSV23 VIS ([link removed])
* Typhoid VIS ([link removed])
* Zoster recombinant VIS ([link removed])
* Zoster live VIS ([link removed])
Related Links
* Access all Turkish-language versions of VISs ([link removed])
* Access allPPSV23 VIS translation ([link removed]) s, as well as the English-language version ([link removed])
* Access alltyphoid VIS translations ([link removed]) , as well as the English-language version ([link removed])
* Access allzoster recombinant VIS translations ([link removed]) , as well as the English-language version ([link removed])
* Access allzoster live VIS translations ([link removed]) , as well as the English-language version ([link removed])
* IAC's VIS web section ([link removed]) for VISs in up to 50 languages ([link removed])
------------------------------------------------------------
IAC POSTS NEW AND UPDATED KAREN TRANSLATIONS OF THE PPSV23, ZOSTER RECOMBINANT, AND ZOSTER LIVE VISS
IAC has posted both new and updated Karen-language versions of the PPSV23, recombinant zoster, and zoster live VISs. IAC thanks St. Peter's Health Partners, Albany, NY, for the donation of these translations.
* PPSV23 VIS ([link removed]) —new!
* Zoster recombinant VIS ([link removed]) —new!
* Zoster live VIS ([link removed]) —updated
Related Links
* Access allKaren-language versions of VISs ([link removed])
* Access allPPSV23 VIS translation ([link removed]) s, as well as the English-language version ([link removed])
* Access allzoster recombinant VIS translations ([link removed]) , as well as the English-language version ([link removed])
* Access allzoster live VIS translations ([link removed]) , as well as the English-language version ([link removed])
* IAC's VIS web section ([link removed]) for VISs in up to 50 languages ([link removed])
------------------------------------------------------------
NEW HINDI-LANGUAGE VERSION OF THE JAPANESE ENCEPHALITIS VIS NOW AVAILABLE
IAC has posted a new Hindi-language version of the Japanese encephalitis VIS. IAC thanks Avinash Bansal, MD, Keshav Swarnkar, and Geeta Bansal, MD, of Kota, India, for donating the translation. Access the updated translation as well as the English-language version below.
* Hindi-language version ([link removed]) —new!
* English-language version ([link removed])
Related Links
* Access all Hindi-language versions of VISs ([link removed])
* IAC's VIS web section ([link removed]) for VISs in up to 50 languages ([link removed])
------------------------------------------------------------
WORLD NEWS
------------------------------------------------------------
DEMOCRATIC REPUBLIC OF THE CONGO, EXPERIENCING WORLD’S LARGEST MEASLES EPIDEMIC, LAUNCHES PHASE 2 OF CAMPAIGN TO VACCINATE 18.9 MILLION CHILDREN BY END OF 2019
According to the World Health Organization (WHO), the Democratic Republic of the Congo (DRC), currently experiencing the world’s largest measles epidemic, has begun its effort to vaccinate 2.2 million children against measles in North Kivu. This effort is phase 2 of its campaign to vaccinate 18.9 million children against measles by end of 2019. The third and final phase of the campaign will target the ten remaining provinces. At this time, the DRC is also dealing with the world's second worst Ebola outbreak.
Read the article on WHO's regional office for Africa website: Measles Vaccination Drive Launched, North Kivu Targets 2.2 Million Children ([link removed]) (12/5/19)
Related Link
* WHO Africa ([link removed]) website
------------------------------------------------------------
PAKISTAN, FIRST COUNTRY WORLDWIDE TO INTRODUCE TYPHOID CONJUGATE VACCINE INTO ITS ROUTINE IMMUNIZATION PROGRAM, VACCINATES 9.4 MILLION CHILDREN AGAINST TYPHOID FEVER IN SINDH PROVINCE
On December 4, the World Health Organization (WHO) reported that Pakistan had vaccinated 9.4 million children against typhoid fever in the Sindh province. This campaign, conducted with the financial support of Gavi, the Vaccine Alliance, and technical support from WHO and UNICEF, included more than 8,000 skilled vaccinators, 20,000 organizers and on-the-ground mobilizers, and more than 2,000 supervisors and monitors between November 18–30, 2019. Pakistan is the first country in the world to introduce the typhoid conjugate vaccine (TCV) into its routine vaccination program.
Read the article on WHO's Pakistan web page: More than 9.4 Million Children Vaccinated against Typhoid Fever in Sindh ([link removed]) (12/4/19)
------------------------------------------------------------
-FEATURED RESOURCES-
------------------------------------------------------------
SEASONAL INFLUENZA ACTIVITY IN THE U.S. ELEVATED FOR FIVE WEEKS AND CONTINUES TO INCREASE. MAKE SURE ALL YOUR PATIENTS ARE GETTING VACCINATED!
According to CDC, seasonal influenza activity in the United States has been elevated for five weeks and continues to increase. CDC stated in its Weekly U.S. Influenza Surveillance Report, FluView ([link removed]) , that as of the week ending December 7, the number of jurisdictions reporting regional or widespread activity increased to 38 this week from 30 last week.
[link removed]
Four new influenza-associated pediatric deaths were reported to CDC during the week ending December 7. A total of 10 influenza-associated pediatric deaths have been reported for the 2019–20 season.
Visit the CDC’s Weekly U.S. Influenza Surveillance Report, FluView ([link removed]) , for details.
Influenza vaccination is recommended for everyone six months of age and older, so please continue to vaccinate all your patients in this age range. If you don't provide influenza vaccination in your clinic, please recommend vaccination to your patients and refer them to a clinic or pharmacy that provides vaccines or to the HealthMap Vaccine Finder ([link removed]) to locate influenza vaccination services near them.
Related Links:
* CDC's Seasonal Flu web section ([link removed])
* CDC's FluView web section ([link removed])
* CDC's Free Resources related to influenza ([link removed])
* IAC's Influenza Educational Materials web page ([link removed]) , ([link removed]) free, ready-to print, and CDC-reviewed
* IAC’s Ask the Experts: Influenza ([link removed]) web page
* IAC’s Vaccines: Influenza ([link removed]) web page
* National Adult and Influenza Immunization Summit ([link removed]) website
* The Summit Buzz: ([link removed]) Newsletter of the National Adult and Influenza Immunization Summit (NAIIS)
* Influenza Vaccine Availability Tracking System—IVATS: ([link removed]) a resource for healthcare settings looking to purchase influenza vaccine (made available from NAIIS)
------------------------------------------------------------
NEW 16-MINUTE PERSONAL BACKGROUND FILM ABOUT DR. MAURICE HILLEMAN RELEASED BY THE VACCINE MAKERS PROJECT AT VEC
A new 16-minute film about Dr. Maurice Hilleman titled Maurice Hilleman: The Man behind the Science, presents the personal background of Dr. Hilleman through memories shared by those who were close to him. It has been released on the Hillemanfilm.com ([link removed]) website, which is sponsored by the Vaccine Education Center at Children's Hospital of Philadelphia.
Dr. Hilleman is considered by many to be the "father of modern vaccines" because of his work in preventing pandemic flu, combining the measles, mumps, and rubella vaccines, and other achievements. His work has been estimated to save about 8 million lives every year.
[link removed]
Read about Dr. Hilleman's life and accomplishments and access a link to watch the film on the About Dr. Hilleman ([link removed]) web page of Hillemanfilm.com.
Access the film directly: Maurice Hilleman: The Man behind the Science ([link removed])
Related Links
* HILLEMAN—A Perilous Quest to Save the World’s Children ([link removed]) , www. hillemanfilm.com ([link removed]) (1 hour)
* The Vaccine Makers Project ([link removed]) , with educational resources and school-based curricula about vaccine science
* The College of Physicians of Philadelphia's The History of Vaccines ([link removed]) website
------------------------------------------------------------
NFID’S REDESIGNED WEBSITE BRINGS TOGETHER THE ORGANIZATION’S VALUABLE INFORMATION AND RESOURCES FOR THE PUBLIC AND HEALTHCARE PROFESSIONALS
The National Foundation for Infectious Diseases (NFID) has redesigned its website, www.nfid.org, to bring together information and resources from its blog and previously separate NFID websites. The navigation menu on the redesigned site provides access to NFID's toolkits, reports, events, and trainings more easily than before. In addition, the website has improved search capabilities and is optimized for mobile devices.
Visit the NFID website ([link removed]) to see the range of valuable information and resources it offers.
Related Link
* NFID ([link removed]) website
------------------------------------------------------------
IAC's comprehensive Vaccinating Adults: A Step-by-Step Guide is available for free download either by chapter or in its entirety (142 pages)
In late 2017, the Immunization Action Coalition (IAC) announced the publication of its new book, Vaccinating Adults: A Step-by-Step Guide (Guide) ([link removed]) .
[link removed]
This completely updated "how to" guide on adult immunization provides easy-to-use, practical information covering essential adult immunization activities. It helps vaccine providers enhance their existing adult immunization services or introduce them into any clinical setting. Topics include:
* setting up for vaccination services,
* storing and handling vaccines,
* deciding which people should receive which vaccines,
* administering vaccines,
* documenting vaccinations (including legal issues), and
* understanding financial considerations and billing information.
In addition, the Guide is filled with hundreds of web addresses and references to help providers stay up to date on the latest immunization information, both now and in the future.
The Guide is available to download/print either by chapter or in its entirety free of charge at www.immunize.org/guide. The downloaded version is suitable for double-sided printing. The National Vaccine Program Office and CDC both supported the development of the Guide and provided early technical review.
The Guide is a uniquely valuable resource to assist providers in increasing adult immunization rates. Be sure to get a copy today!
Related Links
* See Vaccinating Adults: A Step-by-Step Guide ([link removed]) and all its content ([link removed])
* Free download of entire Guide (10.6 MB PDF) ([link removed])
* View the Table of Contents and individual chapters in PDF format:
– Table of Contents ([link removed])
– Step 1: Getting Started ([link removed])
– Step 2: Setting Up for Vaccination Services ([link removed])
– Step 3: Vaccine Storage and Handling ([link removed])
– Step 4: Deciding Whom to Vaccinate ([link removed])
– Step 5: Administering Vaccines ([link removed])
– Step 6: Documentation and Related Issues ([link removed])
– Step 7A: Financial Considerations ([link removed])
– Step 7B: How to Bill for Adult Immunizations ([link removed])
* Promotional flyer for Vaccinating Adults: A Step-by-Step Guide ([link removed])
* IAC’s educational materials (handouts) onadult immunization ([link removed])
------------------------------------------------------------
-JOURNAL ARTICLES AND NEWSLETTERS-
------------------------------------------------------------
JAMA Pediatrics study finds need for strategies to increase MMR vaccination rates among pediatric travelers to reduce measles outbreaks in the U.S.
On December 9, JAMA Pediatrics published a study titled Clinical Practices for Measles-Mumps-Rubella Vaccination among U.S. Pediatric International Travelers ([link removed]) (Emily P. Hyle, et al.). The first and last paragraphs of the abstract are reprinted below.
Importance
The U.S. population is experiencing a resurgence of measles, with more than 1,000 cases during the first 6 months of 2019. Imported measles cases among returning international travelers are the source of most US measles outbreaks, and these importations can be reduced with pretravel measles-mumps-rubella (MMR) vaccination of pediatric travelers. Although it is estimated that children account for less than 10% of U.S. international travelers, pediatric travelers account for 47% of all known measles importations.
Conclusions and Relevance
Although most infant and preschool-aged travelers evaluated at GTEN
[Global TravEpiNet] sites were eligible for pretravel MMR vaccination, only 41.3% were vaccinated during pretravel consultation, mostly because of clinician decision or guardian refusal. Strategies may be needed to improve MMR vaccination among pediatric travelers and to reduce measles importations and outbreaks in the United States.
[link removed]
[link removed]
[link removed]
[link removed]
------------------------------------------------------------
Video of the Week
[link removed]
Steve's Story—Oral Cancer Caused by HPV: This Minnesota Department of Health video tells about Steve, who learned at age 28 that he had oral cancer caused by HPV. His doctor, an oral and maxillofacial surgeon, states that HPV is the leading cause of head and neck cancers, which have increased in recent years. Steve and his wife want everyone to vaccinate their children against HPV.
Visit the VOTW archive ([link removed])
------------------------------------------------------------
[link removed]
------------------------------------------------------------
Follow Us
[link removed]
[link removed]
[link removed]
------------------------------------------------------------
Technically Speaking
[link removed]
Read Dr. Wexler's column for the Vaccine Education Center's monthly newsletter, Vaccine Update
------------------------------------------------------------
Vaccinating Adults:
A Step-by-Step Guide
[link removed]
IAC's 142-page book available for free download ([link removed]) .
------------------------------------------------------------
Calendar of Events
[link removed]
Conferences, meetings, and training opportunities
------------------------------------------------------------
Patient Record Cards
[link removed]
Record cards for patients -- child & teen ([link removed]) , adult ([link removed]) , and lifetime ([link removed]) -- are printed on durable paper and sized to fit in a wallet when folded
------------------------------------------------------------
DVD: Immunization Techniques
[link removed]
Every practice should have this award winning, "how-to" training video
------------------------------------------------------------
Protect Newborns Guidebook
[link removed]
Comprehensive guide Hepatitis B: What Hospitals Need to Do to Protect Newborns ([link removed])
------------------------------------------------------------
Editorial Information
Editor
Deborah L. Wexler, MD (mailto:[email protected])
Managing Editor
Teresa Anderson, DDS, MPH (mailto:[email protected])
Consulting Editors
Marian Deegan, JD ([link removed])
Courtnay Londo, MA (mailto:[email protected])
Jane Myers, MA, EdM (mailto:[email protected])
Assistant Managing Editor
Liv Augusta Anderson, MPP (mailto:[email protected])
------------------------------------------------------------
Abbreviations
AAFP: American Academy of Family Physicians
AAP: American Academy of Pediatrics
ACIP: Advisory Committee on Immunization Practices
CDC: Centers for Disease Control and Prevention
FDA: Food and Drug Administration
IAC: Immunization Action Coalition
MMWR: Morbidity and Mortality Weekly Report
NCIRD: National Center for Immunization and Respiratory Diseases
VIS: Vaccine Information Statement
WHO: World Health Organization
------------------------------------------------------------
About IAC Express
The Immunization Action Coalition welcomes redistribution of this issue of IAC Express or selected articles. When you do so, please add a note that the Immunization Action Coalition is the source of the material and provide a link to this issue ([link removed]) .
If you have trouble receiving or displaying IAC Express messages, visit our online help section ([link removed]) .
IAC Express is supported in part by Grant No.
6NH23IP922550 from the National Center for Immunization and Respiratory Diseases, CDC. Its contents are solely the responsibility of IAC and do not necessarily represent the official views of CDC. IAC Express is also supported by educational grants from the following companies: AstraZeneca, Inc.; Merck Sharp & Dohme Corp.; Pfizer, Inc.; and Sanofi Pasteur.
IAC Express Disclaimer ([link removed])
ISSN: 1526-1786
Our mailing address is:
2550 University Avenue West, Suite 415 North
Saint Paul, MN 55114
Copyright (C) 2019 Immunization Action Coalition
All rights reserved.
To unsubscribe to this publication, go to: [link removed]
==============================================
Unsubscribe [email protected] from this list:
[link removed]
[link removed]
Issue 1469: December 18, 2019
-TOP STORIES-
* Happy holidays from all of us at IAC! We'll be back on January 8. )
* WHO and CDC issue joint press release reporting more than 140,000 died from measles worldwide in 2018 and urging increased global investment in immunization and response
* CDC updates ACIP recommendations on use of anthrax vaccine in the U.S.
* Reminder: National Adult and Influenza Immunization Summit soliciting nominations for its 2020 Immunization Excellence Awards
* IAC's elegantly designed "Vaccines Save Lives" black enamel pins make great gifts for the holidays!
* Flu season is here, so make sure you have IAC's new "FLU VACCINE" buttons for staff and patient stickers on hand!
-VACCINE INFORMATION STATEMENTS-
* Updated translations of the PPSV23 VIS are now available in Arabic, Burmese, Chinese, French, Russian, Somali, Spanish, and Vietnamese
* IAC posts updated translations of both zoster recombinant and zoster live VISs in Arabic, Burmese, Chinese, French, Korean, Russian, Somali, Spanish, and Vietnamese; Spanish-language RTF files also available
* Updated Turkish translations of the PPSV23, typhoid, zoster recombinant, and zoster live VISs now available
* IAC posts new and updated Karen translations of the PPSV23, zoster recombinant, and zoster live VISs
* New Hindi-language version of the Japanese encephalitis VIS now available
WORLD NEWS
* Democratic Republic of the Congo, experiencing world’s largest measles epidemic, launches phase 2 of campaign to vaccinate 18.9 million children by end of 2019
* Pakistan, first country worldwide to introduce typhoid conjugate vaccine into its routine immunization program, vaccinates 9.4 million children against typhoid fever in Sindh province
-FEATURED RESOURCES-
* Seasonal influenza activity in the U.S. elevated for five weeks and continues to increase. Make sure all your patients are getting vaccinated!
* New 16-minute personal background film about Dr. Maurice Hilleman released by the Vaccine Makers Project at VEC
* NFID’s redesigned website brings together the organization’s valuable information and resources for the public and healthcare professionals
* IAC's comprehensive Vaccinating Adults: A Step-by-Step Guide is available for free download either by chapter or in its entirety (142 pages) )
-JOURNAL ARTICLES AND NEWSLETTERS-
* JAMA Pediatrics study finds need for strategies to increase MMR vaccination rates among pediatric travelers to reduce measles outbreaks in the U.S.
------------------------------------------------------------
-TOP STORIES-
------------------------------------------------------------
HAPPY HOLIDAYS FROM ALL OF US AT IAC! WE'LL BE BACK ON JANUARY 8.
All of us at the Immunization Action Coalition (IAC) wish you, our readers, a safe, happy, and relaxing holiday season. Because of the holiday schedule, we will not publish another issue of IAC Express until January 8. The IAC office will be closed on December 24 and 25, as well as January 1.
Happy holidays!
------------------------------------------------------------
WHO AND CDC ISSUE JOINT PRESS RELEASE REPORTING MORE THAN 140,000 DIED FROM MEASLES WORLDWIDE IN 2018 AND URGING INCREASED GLOBAL INVESTMENT IN IMMUNIZATION AND RESPONSE
On December 5, the World Health Organization (WHO) and CDC issued a joint press release ([link removed]) highlighting the surge in worldwide measles cases in 2018. The press release stresses the risk for complications among infants and young children, with most deaths from complications occurring in children under 5 years of age. Populations that are hardest hit by measles outbreaks are those in the poorest countries, especially in sub-Saharan Africa. The joint statement calls for ongoing investment in high-quality national immunization programs and disease surveillance in addition to improved outbreak response.
Access the complete press release: More than 140,000 Die from Measles as Cases Surge Worldwide ([link removed]) (12/5/19)
Related Links
* MMWR: Progress toward Regional Measles Elimination—Worldwide, 2000–2017 ([link removed]) (11/30/18)
* WHO news release: Measles Cases Spike Globally Due to Gaps in Vaccination Coverage ([link removed]) (11/29/18)
------------------------------------------------------------
CDC UPDATES ACIP RECOMMENDATIONS ON USE OF ANTHRAX VACCINE IN THE U.S.
CDC published Use of Anthrax Vaccine in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2019 ([link removed]) in the December 13 issue of MMWR Recommendations and Reports. The first paragraph of the summary for the press is reprinted below.
This report updates the 2009 recommendations from the CDC Advisory Committee on Immunization Practices (ACIP) regarding use of anthrax vaccine in the United States (Wright JG, Quinn CP, Shadomy S, Messonnier N. Use of anthrax vaccine in the United States: recommendations of the Advisory Committee on Immunization Practices [ACIP)], 2009. MMWR Recomm Rep 2010;59[No. RR-6]). The report 1) summarizes data on estimated efficacy in humans using a correlates of protection model and safety data published since the last ACIP review, 2) provides updated guidance for use of anthrax vaccine adsorbed (AVA) for preexposure prophylaxis (PrEP) and in conjunction with antimicrobials for postexposure prophylaxis (PEP), 3) provides updated guidance regarding PrEP vaccination of emergency and other responders, 4) summarizes the available data on an investigational anthrax vaccine (AV7909), and 5) discusses the use of anthrax antitoxins for PEP.
Access the complete MMWR article:
* In PDF format ([link removed])
* In HTML format ([link removed])
Related Link
* MMWR main page ([link removed]) provides access to MMWR Weekly, MMWR Recommendations and Reports, MMWR Surveillance Summaries, and MMWR Supplements
------------------------------------------------------------
REMINDER: NATIONAL ADULT AND INFLUENZA IMMUNIZATION SUMMIT SOLICITING NOMINATIONS FOR ITS 2020 IMMUNIZATION EXCELLENCE AWARDS
The National Adult and Influenza Immunization Summit (NAIIS) is soliciting nominations for the 2020 NAIIS Immunization Excellence Awards ([link removed]) . The 2020 awards recognize individuals and organizations that have made extraordinary contributions towards improving vaccination rates within their communities during 2019. Awardees exemplify the meaning of the "immunization neighborhood" (collaboration, coordination, and communication among immunization stakeholders dedicated to meeting the immunization needs of the patient and protecting the community from vaccine-preventable diseases).
A National Winner will be selected for each award category, and where appropriate, an Honorable Mention recipient. The winners will be presented with their awards at the NAIIS meeting to be held on May 18 in Atlanta, GA, in conjunction with CDC’s National Immunization Conference. The National Winners in each category will be invited to present their programs at the NAIIS meeting.
Nominations deadline is February 1, 2020.
Access information on the award categories and the nomination form ([link removed]) .
Related Links
* NAIIS ([link removed]) website
* NAIIS newsletter: The Summit Buzz ([link removed])
------------------------------------------------------------
IAC'S ELEGANTLY DESIGNED "VACCINES SAVE LIVES" BLACK ENAMEL PINS MAKE GREAT GIFTS FOR THE HOLIDAYS!
IAC’s new elegantly designed “Vaccines Save Lives” pin ([link removed]) on hard black enamel with gold lettering and edges makes a meaningful gift for people who care about immunization.
[link removed]
The pin is a stick-through-post variety with the back end covered by a round rubber cap that holds the pin securely. A gold metal spring-lock clasp is also provided. The pin makes a refined statement, measuring 1.125" x 0.75".
Wear these pins on clothing, ([link removed]) uniforms, lab coats, tote bags, and backpacks to show that you value vaccines!
[link removed]
Click here for "Vaccines Save Lives" pins pricing and ordering information. ([link removed])
Visit Shop IAC for additional items ([link removed]) , including "FLU VACCINE" buttons and stickers, patient record cards, and a vaccine administration training video.
------------------------------------------------------------
FLU SEASON IS HERE, SO MAKE SURE YOU HAVE IAC'S NEW "FLU VACCINE" BUTTONS FOR STAFF AND PATIENT STICKERS ON HAND!
IAC's “FLU VACCINE” buttons and stickers ([link removed]) are ready to ship! Their bright red color helps broadcast your important message about the need for flu vaccination. And the cost is nominal.
[link removed]
“FLU VACCINE” BUTTONS
The button measures 1.25" across and carries a bold message! Pin on lab coats, uniforms, other clothing, tote bags, or backpacks to show support for flu vaccine.
Buttons are delivered in bags of 10 buttons per bag.
Click here for pricing and ordering information for "FLU VACCINE" buttons ([link removed]) .
“FLU VACCINE” STICKERS
Measuring 1.5" across and printed on Avery labels, theses stickers adhere well to clothing and have an easy-peel-off back.
Stickers are delivered to you cut individually (not on rolls)—available in bundles of 100.
Click here for pricing and ordering information for “FLU VACCINE” stickers. ([link removed])
Visit Shop IAC for additional items ([link removed]) , including "Vaccines Save Lives" enamel pins, patient record cards, and a vaccine administration training video.
------------------------------------------------------------
-VACCINE INFORMATION STATEMENTS-
------------------------------------------------------------
UPDATED TRANSLATIONS OF THE PPSV23 VIS ARE NOW AVAILABLE IN ARABIC, BURMESE, CHINESE, FRENCH, RUSSIAN, SOMALI, SPANISH, AND VIETNAMESE
IAC recently posted updated Arabic, Burmese, Chinese, French, Russian, Somali, Spanish, and Vietnamese translations of the PPSV23 VIS ([link removed]) . Access these updated translated versions below.
* Arabic-language version ([link removed])
* Burmese-language version ([link removed])
* Chinese-Simplified version ([link removed])
* Chinese-Traditional version ([link removed])
* French-language version ([link removed])
* Russian-language version ([link removed])
* Somali-language version ([link removed])
* Spanish-language version ([link removed])
* Spanish-language RTF version ([link removed])
* Vietnamese-language version ([link removed])
Related Links
* Access all PPSV23 VIS translations ([link removed]) , as well as the English-language version ([link removed])
* Access allhttp://www.immunize.org/vis/vis_amharic.aspArabic-language versions of VISs ([link removed])
* Access allBurmese-language versions of VISs ([link removed])
* Access allhttp://www.immunize.org/vis/vis_amharic.aspChinese-language versions of VISs ([link removed])
* Access allhttp://www.immunize.org/vis/vis_amharic.aspFrench-language versions of VISs ([link removed])
* Access allRussian-language versions of VISs ([link removed])
* Access allhttp://www.immunize.org/vis/vis_amharic.aspSomali-language versions of VISs ([link removed])
* Access allhttp://www.immunize.org/vis/vis_amharic.aspSpanish-language versions of VISs ([link removed])
* Access all ([link removed]) Vietnamese-language versions of VISs ([link removed])
* Access allVIS translations categorized by language ([link removed])
* IAC's VIS web section ([link removed]) for VISs in up to 50 languages ([link removed])
* CDC's What's New with VISs ([link removed]) web section
* CDC's VIS ([link removed]) web section
* View more than 300 CDC-reviewed, ready-to-print IACEducational Materials for Patients and Staff ([link removed])
------------------------------------------------------------
IAC POSTS UPDATED TRANSLATIONS OF BOTH ZOSTER RECOMBINANT AND ZOSTER LIVE VISS IN ARABIC, BURMESE, CHINESE, FRENCH, KOREAN, RUSSIAN, SOMALI, SPANISH, AND VIETNAMESE; SPANISH-LANGUAGE RTF FILES ALSO AVAILABLE
IAC recently posted updated Arabic, Burmese, Chinese, French, Korean, Russian, Somali, Spanish, and Vietnamese translations of the VISs for both the zoster recombinant (Shingrix, GlaxoSmithKline) ([link removed]) and the zoster live vaccine (Zostavax, Merck) ([link removed]) . Access the updated translated versions below.
Zoster recombinant VIS
* Arabic-language version ([link removed])
* Burmese-language version ([link removed])
* Chinese-Simplified version ([link removed])
* Chinese-Traditional version ([link removed])
* French-language version ([link removed])
* Korean-language version ([link removed])
* Russian-language version ([link removed])
* Somali-language version ([link removed])
* Spanish-language version ([link removed]) (PDF)
* Spanish-language version ([link removed]) (RTF)
* Vietnamese-language version ([link removed])
Zoster live VIS
* Arabic-language version ([link removed])
* Burmese-language version ([link removed])
* Chinese-Simplified version ([link removed])
* Chinese-Traditional version ([link removed])
* French-language version ([link removed])
* Korean-language version ([link removed])
* Russian-language version ([link removed])
* Somali-language version ([link removed])
* Spanish-language version ([link removed]) (PDF)
* Spanish-language version ([link removed]) (RTF)
* Vietnamese-language version ([link removed])
RTF files are intended for use in electronic systems, such as electronic medical records, immunization information systems, or other electronic databases. CDC supplies RTF files of the English-language VISs, and IAC provides Spanish RTF files of VISs for each routinely recommended vaccine.
Related Links
* Access all zoster recombinant VIS translations ([link removed]) , as well as the English-language version ([link removed])
* Access all zoster live VIS translations ([link removed]) , as well as the English-language version ([link removed])
* Access allhttp://www.immunize.org/vis/vis_amharic.aspArabic-language versions of VISs ([link removed])
* Access allhttp://www.immunize.org/vis/vis_amharic.aspBurmese-language versions of VISs ([link removed])
* Access all Chinese-language versions of VISs ([link removed])
* Access allhttp://www.immunize.org/vis/vis_amharic.aspFrench-language versions of VISs ([link removed])
* Access allhttp://www.immunize.org/vis/vis_amharic.aspKorean-language versions of VISs ([link removed])
* Access allhttp://www.immunize.org/vis/vis_amharic.aspRussian-language versions of VISs ([link removed])
* Access allhttp://www.immunize.org/vis/vis_amharic.aspSomali-language versions of VISs ([link removed])
* Access allhttp://www.immunize.org/vis/vis_amharic.aspSpanish-language versions of VIS ([link removed]) s ([link removed])
* Access allhttp://www.immunize.org/vis/vis_amharic.aspVietnamese-language versions of VISs ([link removed])
* Access allVIS translations categorized by language ([link removed])
* IAC's VIS web section ([link removed]) for VISs in up to 50 languages ([link removed])
* CDC's What's New with VISs ([link removed]) web section
* CDC's VIS ([link removed]) web section
* View more than 300 CDC-reviewed, ready-to-print IACEducational Materials for Patients and Staff ([link removed])
------------------------------------------------------------
UPDATED TURKISH TRANSLATIONS OF THE PPSV23, TYPHOID, ZOSTER RECOMBINANT, AND ZOSTER LIVE VISS NOW AVAILABLE
IAC has posted updated Turkish-language versions of the PPSV23, typhoid, zoster recombinant, and zoster live VISs. IAC thanks Betül Polatdemir, MD, and Sibel Bostancıoğlu, MD, Occupational and Environmental Diseases Hospital, Ankara, Turkey, for their donation of the Turkish translations. Access these Turkish-language versions below.
* PPSV23 VIS ([link removed])
* Typhoid VIS ([link removed])
* Zoster recombinant VIS ([link removed])
* Zoster live VIS ([link removed])
Related Links
* Access all Turkish-language versions of VISs ([link removed])
* Access allPPSV23 VIS translation ([link removed]) s, as well as the English-language version ([link removed])
* Access alltyphoid VIS translations ([link removed]) , as well as the English-language version ([link removed])
* Access allzoster recombinant VIS translations ([link removed]) , as well as the English-language version ([link removed])
* Access allzoster live VIS translations ([link removed]) , as well as the English-language version ([link removed])
* IAC's VIS web section ([link removed]) for VISs in up to 50 languages ([link removed])
------------------------------------------------------------
IAC POSTS NEW AND UPDATED KAREN TRANSLATIONS OF THE PPSV23, ZOSTER RECOMBINANT, AND ZOSTER LIVE VISS
IAC has posted both new and updated Karen-language versions of the PPSV23, recombinant zoster, and zoster live VISs. IAC thanks St. Peter's Health Partners, Albany, NY, for the donation of these translations.
* PPSV23 VIS ([link removed]) —new!
* Zoster recombinant VIS ([link removed]) —new!
* Zoster live VIS ([link removed]) —updated
Related Links
* Access allKaren-language versions of VISs ([link removed])
* Access allPPSV23 VIS translation ([link removed]) s, as well as the English-language version ([link removed])
* Access allzoster recombinant VIS translations ([link removed]) , as well as the English-language version ([link removed])
* Access allzoster live VIS translations ([link removed]) , as well as the English-language version ([link removed])
* IAC's VIS web section ([link removed]) for VISs in up to 50 languages ([link removed])
------------------------------------------------------------
NEW HINDI-LANGUAGE VERSION OF THE JAPANESE ENCEPHALITIS VIS NOW AVAILABLE
IAC has posted a new Hindi-language version of the Japanese encephalitis VIS. IAC thanks Avinash Bansal, MD, Keshav Swarnkar, and Geeta Bansal, MD, of Kota, India, for donating the translation. Access the updated translation as well as the English-language version below.
* Hindi-language version ([link removed]) —new!
* English-language version ([link removed])
Related Links
* Access all Hindi-language versions of VISs ([link removed])
* IAC's VIS web section ([link removed]) for VISs in up to 50 languages ([link removed])
------------------------------------------------------------
WORLD NEWS
------------------------------------------------------------
DEMOCRATIC REPUBLIC OF THE CONGO, EXPERIENCING WORLD’S LARGEST MEASLES EPIDEMIC, LAUNCHES PHASE 2 OF CAMPAIGN TO VACCINATE 18.9 MILLION CHILDREN BY END OF 2019
According to the World Health Organization (WHO), the Democratic Republic of the Congo (DRC), currently experiencing the world’s largest measles epidemic, has begun its effort to vaccinate 2.2 million children against measles in North Kivu. This effort is phase 2 of its campaign to vaccinate 18.9 million children against measles by end of 2019. The third and final phase of the campaign will target the ten remaining provinces. At this time, the DRC is also dealing with the world's second worst Ebola outbreak.
Read the article on WHO's regional office for Africa website: Measles Vaccination Drive Launched, North Kivu Targets 2.2 Million Children ([link removed]) (12/5/19)
Related Link
* WHO Africa ([link removed]) website
------------------------------------------------------------
PAKISTAN, FIRST COUNTRY WORLDWIDE TO INTRODUCE TYPHOID CONJUGATE VACCINE INTO ITS ROUTINE IMMUNIZATION PROGRAM, VACCINATES 9.4 MILLION CHILDREN AGAINST TYPHOID FEVER IN SINDH PROVINCE
On December 4, the World Health Organization (WHO) reported that Pakistan had vaccinated 9.4 million children against typhoid fever in the Sindh province. This campaign, conducted with the financial support of Gavi, the Vaccine Alliance, and technical support from WHO and UNICEF, included more than 8,000 skilled vaccinators, 20,000 organizers and on-the-ground mobilizers, and more than 2,000 supervisors and monitors between November 18–30, 2019. Pakistan is the first country in the world to introduce the typhoid conjugate vaccine (TCV) into its routine vaccination program.
Read the article on WHO's Pakistan web page: More than 9.4 Million Children Vaccinated against Typhoid Fever in Sindh ([link removed]) (12/4/19)
------------------------------------------------------------
-FEATURED RESOURCES-
------------------------------------------------------------
SEASONAL INFLUENZA ACTIVITY IN THE U.S. ELEVATED FOR FIVE WEEKS AND CONTINUES TO INCREASE. MAKE SURE ALL YOUR PATIENTS ARE GETTING VACCINATED!
According to CDC, seasonal influenza activity in the United States has been elevated for five weeks and continues to increase. CDC stated in its Weekly U.S. Influenza Surveillance Report, FluView ([link removed]) , that as of the week ending December 7, the number of jurisdictions reporting regional or widespread activity increased to 38 this week from 30 last week.
[link removed]
Four new influenza-associated pediatric deaths were reported to CDC during the week ending December 7. A total of 10 influenza-associated pediatric deaths have been reported for the 2019–20 season.
Visit the CDC’s Weekly U.S. Influenza Surveillance Report, FluView ([link removed]) , for details.
Influenza vaccination is recommended for everyone six months of age and older, so please continue to vaccinate all your patients in this age range. If you don't provide influenza vaccination in your clinic, please recommend vaccination to your patients and refer them to a clinic or pharmacy that provides vaccines or to the HealthMap Vaccine Finder ([link removed]) to locate influenza vaccination services near them.
Related Links:
* CDC's Seasonal Flu web section ([link removed])
* CDC's FluView web section ([link removed])
* CDC's Free Resources related to influenza ([link removed])
* IAC's Influenza Educational Materials web page ([link removed]) , ([link removed]) free, ready-to print, and CDC-reviewed
* IAC’s Ask the Experts: Influenza ([link removed]) web page
* IAC’s Vaccines: Influenza ([link removed]) web page
* National Adult and Influenza Immunization Summit ([link removed]) website
* The Summit Buzz: ([link removed]) Newsletter of the National Adult and Influenza Immunization Summit (NAIIS)
* Influenza Vaccine Availability Tracking System—IVATS: ([link removed]) a resource for healthcare settings looking to purchase influenza vaccine (made available from NAIIS)
------------------------------------------------------------
NEW 16-MINUTE PERSONAL BACKGROUND FILM ABOUT DR. MAURICE HILLEMAN RELEASED BY THE VACCINE MAKERS PROJECT AT VEC
A new 16-minute film about Dr. Maurice Hilleman titled Maurice Hilleman: The Man behind the Science, presents the personal background of Dr. Hilleman through memories shared by those who were close to him. It has been released on the Hillemanfilm.com ([link removed]) website, which is sponsored by the Vaccine Education Center at Children's Hospital of Philadelphia.
Dr. Hilleman is considered by many to be the "father of modern vaccines" because of his work in preventing pandemic flu, combining the measles, mumps, and rubella vaccines, and other achievements. His work has been estimated to save about 8 million lives every year.
[link removed]
Read about Dr. Hilleman's life and accomplishments and access a link to watch the film on the About Dr. Hilleman ([link removed]) web page of Hillemanfilm.com.
Access the film directly: Maurice Hilleman: The Man behind the Science ([link removed])
Related Links
* HILLEMAN—A Perilous Quest to Save the World’s Children ([link removed]) , www. hillemanfilm.com ([link removed]) (1 hour)
* The Vaccine Makers Project ([link removed]) , with educational resources and school-based curricula about vaccine science
* The College of Physicians of Philadelphia's The History of Vaccines ([link removed]) website
------------------------------------------------------------
NFID’S REDESIGNED WEBSITE BRINGS TOGETHER THE ORGANIZATION’S VALUABLE INFORMATION AND RESOURCES FOR THE PUBLIC AND HEALTHCARE PROFESSIONALS
The National Foundation for Infectious Diseases (NFID) has redesigned its website, www.nfid.org, to bring together information and resources from its blog and previously separate NFID websites. The navigation menu on the redesigned site provides access to NFID's toolkits, reports, events, and trainings more easily than before. In addition, the website has improved search capabilities and is optimized for mobile devices.
Visit the NFID website ([link removed]) to see the range of valuable information and resources it offers.
Related Link
* NFID ([link removed]) website
------------------------------------------------------------
IAC's comprehensive Vaccinating Adults: A Step-by-Step Guide is available for free download either by chapter or in its entirety (142 pages)
In late 2017, the Immunization Action Coalition (IAC) announced the publication of its new book, Vaccinating Adults: A Step-by-Step Guide (Guide) ([link removed]) .
[link removed]
This completely updated "how to" guide on adult immunization provides easy-to-use, practical information covering essential adult immunization activities. It helps vaccine providers enhance their existing adult immunization services or introduce them into any clinical setting. Topics include:
* setting up for vaccination services,
* storing and handling vaccines,
* deciding which people should receive which vaccines,
* administering vaccines,
* documenting vaccinations (including legal issues), and
* understanding financial considerations and billing information.
In addition, the Guide is filled with hundreds of web addresses and references to help providers stay up to date on the latest immunization information, both now and in the future.
The Guide is available to download/print either by chapter or in its entirety free of charge at www.immunize.org/guide. The downloaded version is suitable for double-sided printing. The National Vaccine Program Office and CDC both supported the development of the Guide and provided early technical review.
The Guide is a uniquely valuable resource to assist providers in increasing adult immunization rates. Be sure to get a copy today!
Related Links
* See Vaccinating Adults: A Step-by-Step Guide ([link removed]) and all its content ([link removed])
* Free download of entire Guide (10.6 MB PDF) ([link removed])
* View the Table of Contents and individual chapters in PDF format:
– Table of Contents ([link removed])
– Step 1: Getting Started ([link removed])
– Step 2: Setting Up for Vaccination Services ([link removed])
– Step 3: Vaccine Storage and Handling ([link removed])
– Step 4: Deciding Whom to Vaccinate ([link removed])
– Step 5: Administering Vaccines ([link removed])
– Step 6: Documentation and Related Issues ([link removed])
– Step 7A: Financial Considerations ([link removed])
– Step 7B: How to Bill for Adult Immunizations ([link removed])
* Promotional flyer for Vaccinating Adults: A Step-by-Step Guide ([link removed])
* IAC’s educational materials (handouts) onadult immunization ([link removed])
------------------------------------------------------------
-JOURNAL ARTICLES AND NEWSLETTERS-
------------------------------------------------------------
JAMA Pediatrics study finds need for strategies to increase MMR vaccination rates among pediatric travelers to reduce measles outbreaks in the U.S.
On December 9, JAMA Pediatrics published a study titled Clinical Practices for Measles-Mumps-Rubella Vaccination among U.S. Pediatric International Travelers ([link removed]) (Emily P. Hyle, et al.). The first and last paragraphs of the abstract are reprinted below.
Importance
The U.S. population is experiencing a resurgence of measles, with more than 1,000 cases during the first 6 months of 2019. Imported measles cases among returning international travelers are the source of most US measles outbreaks, and these importations can be reduced with pretravel measles-mumps-rubella (MMR) vaccination of pediatric travelers. Although it is estimated that children account for less than 10% of U.S. international travelers, pediatric travelers account for 47% of all known measles importations.
Conclusions and Relevance
Although most infant and preschool-aged travelers evaluated at GTEN
[Global TravEpiNet] sites were eligible for pretravel MMR vaccination, only 41.3% were vaccinated during pretravel consultation, mostly because of clinician decision or guardian refusal. Strategies may be needed to improve MMR vaccination among pediatric travelers and to reduce measles importations and outbreaks in the United States.
[link removed]
[link removed]
[link removed]
[link removed]
------------------------------------------------------------
Video of the Week
[link removed]
Steve's Story—Oral Cancer Caused by HPV: This Minnesota Department of Health video tells about Steve, who learned at age 28 that he had oral cancer caused by HPV. His doctor, an oral and maxillofacial surgeon, states that HPV is the leading cause of head and neck cancers, which have increased in recent years. Steve and his wife want everyone to vaccinate their children against HPV.
Visit the VOTW archive ([link removed])
------------------------------------------------------------
[link removed]
------------------------------------------------------------
Follow Us
[link removed]
[link removed]
[link removed]
------------------------------------------------------------
Technically Speaking
[link removed]
Read Dr. Wexler's column for the Vaccine Education Center's monthly newsletter, Vaccine Update
------------------------------------------------------------
Vaccinating Adults:
A Step-by-Step Guide
[link removed]
IAC's 142-page book available for free download ([link removed]) .
------------------------------------------------------------
Calendar of Events
[link removed]
Conferences, meetings, and training opportunities
------------------------------------------------------------
Patient Record Cards
[link removed]
Record cards for patients -- child & teen ([link removed]) , adult ([link removed]) , and lifetime ([link removed]) -- are printed on durable paper and sized to fit in a wallet when folded
------------------------------------------------------------
DVD: Immunization Techniques
[link removed]
Every practice should have this award winning, "how-to" training video
------------------------------------------------------------
Protect Newborns Guidebook
[link removed]
Comprehensive guide Hepatitis B: What Hospitals Need to Do to Protect Newborns ([link removed])
------------------------------------------------------------
Editorial Information
Editor
Deborah L. Wexler, MD (mailto:[email protected])
Managing Editor
Teresa Anderson, DDS, MPH (mailto:[email protected])
Consulting Editors
Marian Deegan, JD ([link removed])
Courtnay Londo, MA (mailto:[email protected])
Jane Myers, MA, EdM (mailto:[email protected])
Assistant Managing Editor
Liv Augusta Anderson, MPP (mailto:[email protected])
------------------------------------------------------------
Abbreviations
AAFP: American Academy of Family Physicians
AAP: American Academy of Pediatrics
ACIP: Advisory Committee on Immunization Practices
CDC: Centers for Disease Control and Prevention
FDA: Food and Drug Administration
IAC: Immunization Action Coalition
MMWR: Morbidity and Mortality Weekly Report
NCIRD: National Center for Immunization and Respiratory Diseases
VIS: Vaccine Information Statement
WHO: World Health Organization
------------------------------------------------------------
About IAC Express
The Immunization Action Coalition welcomes redistribution of this issue of IAC Express or selected articles. When you do so, please add a note that the Immunization Action Coalition is the source of the material and provide a link to this issue ([link removed]) .
If you have trouble receiving or displaying IAC Express messages, visit our online help section ([link removed]) .
IAC Express is supported in part by Grant No.
6NH23IP922550 from the National Center for Immunization and Respiratory Diseases, CDC. Its contents are solely the responsibility of IAC and do not necessarily represent the official views of CDC. IAC Express is also supported by educational grants from the following companies: AstraZeneca, Inc.; Merck Sharp & Dohme Corp.; Pfizer, Inc.; and Sanofi Pasteur.
IAC Express Disclaimer ([link removed])
ISSN: 1526-1786
Our mailing address is:
2550 University Avenue West, Suite 415 North
Saint Paul, MN 55114
Copyright (C) 2019 Immunization Action Coalition
All rights reserved.
To unsubscribe to this publication, go to: [link removed]
==============================================
Unsubscribe [email protected] from this list:
[link removed]
Message Analysis
- Sender: Immunization Action Coalition
- Political Party: n/a
- Country: United States
- State/Locality: n/a
- Office: n/a
-
Email Providers:
- MailChimp